|
|
Post by buyitonsale on Jul 14, 2021 14:41:11 GMT -5
Control what you can control.
So, I will continue to accumulate the stock under 5 and wait for any announcements from UTHR related to Tyvaso DPI.
PDUFA date is only 3 months away.
|
|
|
|
Post by sweedee79 on Jul 14, 2021 14:47:20 GMT -5
I'm thinking that Martine and lawyers were already aware this could happen... I'm betting they are ready for it.. and the person behind it all is none other than liquidia.. who else could it be besides short sellers..
Martine too smart to just let this happen.. unbelievable how cut throat this business is.. or any other business for that matter.. it's hard to not become very cynical.. some people will just try absolutely anything..
|
|
|
|
Post by mytakeonit on Jul 14, 2021 14:49:55 GMT -5
And I will continue to buy all the cheap shares I can ... despite my wife's warnings !!!
But, that's mytakeonit
|
|
|
|
Post by mango on Jul 14, 2021 14:54:49 GMT -5
I tried calling the Scott Lassman law firm and left a voicemail. I also sent this email. I encourage everyone to do the same. We will not put up with this chit. www.lassmanfdalaw.com/ |
|
|
|
Post by jkendra on Jul 14, 2021 14:59:17 GMT -5
We are stronger in numbers.
|
|
|
|
Post by mango on Jul 14, 2021 15:37:03 GMT -5
Reply from Scott Lassman  |
|
|
|
Post by awesomo on Jul 14, 2021 15:42:56 GMT -5
I mean, him responding at all is probably as good as you can hope for.
|
|
|
|
Post by cedafuntennis on Jul 14, 2021 15:51:25 GMT -5
My thinking exactly. It smells Liquida and once the FDA or FTC turns it down, UTHR should add it to the lawsuit and demand hefty compensation as well as punitive damages from them. Then they should share the punitive damages with us the shareholders.
|
|
|
|
Post by sweedee79 on Jul 14, 2021 15:53:16 GMT -5
Oh wow.. how slimey is that? This is what this world has come to.. so much for making an honest buck..
I've been reading about citizen petitions... They are a big problem for the fda... Very often used as a legal loophole by BP to stop drugs from going generic when patents run out and it does in fact cause delays and costs the fda money and time..
It was originally meant as a way for people to address legitimate concerns.. eventually everything that is well meant ends up getting used falsely.. in other words this petition is nothing more than a lie.. and this dude knows it..
|
|
|
|
Post by sweedee79 on Jul 14, 2021 16:14:35 GMT -5
|
|
|
|
Post by harryx1 on Jul 14, 2021 16:23:49 GMT -5
This definitely has Liquidia and it's investor's finger prints all over it. The reason Afrezza has a black box warning is because it was a non-lung disease that was being targeted through the lungs. So if someone had an underlying condition and didn't know it, it would be found and protect the patient and company. Patients targeted in PAH and PH-ILD already have an underlying lung issue and are being treated by a Dr. that already know this. As many of us know, FDKP has been tested through studies going back to 2005. LIQ861 excipient isn't even disclosed and nothing can be found on it. I believe their excipient is sugar based vs. FDKP is salt based. From LQDA's 2019 Prospectus... www.liquidia.com/node/7196/htmlWe face significant competition from large pharmaceutical companies, among others, and our operating results will suffer if we are unable to compete effectively. We face significant competition from industry players worldwide, including large multi-national pharmaceutical companies, other emerging or smaller pharmaceutical companies, as well as universities and other research institutions. Many of our competitors have substantially greater financial, technical and other resources, such as a larger research and development staff, and more experience in manufacturing and marketing, than we do. As a result, these companies may obtain marketing approval for their product candidates more quickly than we are able to and be more successful in commercializing their products than us. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaboration arrangements that they enter into with large, established companies. We may also face competition as a result of advances in the commercial applicability of new technologies and greater availability of capital for investment in such technologies. Our competitors may also invest heavily in the discovery and development of novel drug products that could make our product candidates less competitive or may file FDA citizen petitions which may delay the approval process for our product candidates. |
|
|
|
Post by mango on Jul 14, 2021 16:40:36 GMT -5
This CP is a blatant attempt to spread misinformation and to delay FDA approval of Tyvaso DPI. FDA will completely dismiss this child’s play.
Fact is, FDKP has already been proven to be a safe, inert particle carrier and is FDA approved. No adverse events were seen in the Tyvaso DPI preclinical and clinical studies to warrant concern.
The petition will die.
As for Scott Lassman. Dude is no better than scum like Looking for Diogenes and Martin Shkreli.
Tyvaso DPI will be approved this year.
|
|
|
|
Post by dh4mizzou on Jul 14, 2021 17:01:26 GMT -5
Just wondering. Could we as shareholders and the current Tyvaso users file a class action lawsuit against Liquidia and this lawfirm?
On a slightly different tack. Could a FOIA request be submitted to discover the name of the "petitioner" the firm is working for?
|
|
|
|
Post by cretin11 on Jul 14, 2021 17:28:57 GMT -5
Just wondering. Could we as shareholders and the current Tyvaso users file a class action lawsuit against Liquidia and this lawfirm? On a slightly different tack. Could a FOIA request be submitted to discover the name of the "petitioner" the firm is working for? No as to the first question, maybe as to the second. IMO |
|
|
|
Post by mango on Jul 14, 2021 17:32:30 GMT -5
Just wondering. Could we as shareholders and the current Tyvaso users file a class action lawsuit against Liquidia and this lawfirm? On a slightly different tack. Could a FOIA request be submitted to discover the name of the "petitioner" the firm is working for? FOIA would likely not work in this case, we’d have to file something against the law firm most likely and take it to court to discover the client, but I’m not an attorney so don’t take my word for it. However, it is clear to me that Scott Lassman is working for Liquidia in this CP. He states on his website he works for pharmaceutical companies and files Citizen Petitions. It is clear who the client is, but also just using Occam’s razor we still arrive to: Liquidia   |
|
